What Atle Fund Management AB reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 1381843 · Filed Jul 24, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 189.4K |
| +459.4% |
| $24.3M |
| 6.5% |
JNJJohnson & Johnson | 85.4K | −7.5% | $21.7M | 5.8% |
ABBVAbbVie Inc. | 64.3K | −40.5% | $16.2M | 4.4% |
CVSCVS HEALTH Corp | 146.1K | +514.6% | $15.1M | 4.1% |
TMOThermo Fisher Scientific Inc. | 27.9K | +21.2% | $14M | 3.8% |
RVMDRevolution Medicines, Inc. | 73.1K | −88.2% | $13.7M | 3.7% |
BIIBBiogen Inc. | 62.8K | New | $13.6M | 3.6% |
NBIXNeurocrine Biosciences Inc | 72.9K | −18.7% | $12.3M | 3.3% |
MIRMMirum Pharmaceuticals, Inc. | 100.8K | −48.5% | $11.8M | 3.2% |
ALKSAlkermes plc. | 213.3K | −12.0% | $11.2M | 3% |
IONSIonis Pharmaceuticals Inc | 137.1K | +392.0% | $10.9M | 2.9% |
ONCBeOne Medicines Ltd. | 35.2K | −15.7% | $10M | 2.7% |
ISRGIntuitive Surgical Inc | 24.7K | −65.2% | $9.8M | 2.6% |
SYKStryker Corp | 30.3K | +12.8% | $9.5M | 2.6% |
VRTXVertex Pharmaceuticals Inc | 19.1K | −16.8% | $9.5M | 2.6% |
EWEdwards Lifesciences Corp | 103.2K | −3.1% | $9.3M | 2.5% |
BBIOBridgeBio Pharma, Inc. | 124.7K | +12.0% | $9.3M | 2.5% |
KRYSKrystal Biotech, Inc. | 24K | −36.1% | $8.9M | 2.4% |
CORCencora, Inc. | 31.1K | +32.6% | $8.8M | 2.4% |
NAMSNewAmsterdam Pharma Co N.V. | 248.8K | +162.5% | $8.4M | 2.3% |
ABVXAbivax S.A. | 58.2K | +84.1% | $7.8M | 2.1% |
INCYIncyte Corp | 57K | +12.1% | $6.5M | 1.7% |
IRTCiRhythm Holdings, Inc. | 54.1K | +142.4% | $6.4M | 1.7% |
BSXBoston Scientific Corp | 146.4K | +262.0% | $6.2M | 1.7% |
INSMINSMED Inc | 58.4K | −40.1% | $6.2M | 1.7% |
TNGXTango Therapeutics, Inc. | 198.6K | +563.7% | $6.2M | 1.7% |
GILDGilead Sciences, Inc. | 46.1K | −3.8% | $5.8M | 1.6% |
CAHCardinal Health Inc | 23.6K | −78.3% | $5.6M | 1.5% |
ORKAOruka Therapeutics, Inc. | 54.9K | New | $5.2M | 1.4% |
SYRESpyre Therapeutics, Inc. | 57K | −9.1% | $5.1M | 1.4% |
DXCMDexCom Inc | 71.8K | −87.7% | $4.8M | 1.3% |
BCAXBicara Therapeutics Inc. | 145.7K | −87.5% | $4.3M | 1.2% |
IDYAIDEAYA Biosciences, Inc. | 94.5K | +203.5% | $3.5M | 0.9% |
CELCCelcuity Inc. | 33.3K | −76.4% | $3.5M | 0.9% |
IRONDisc Medicine, Inc. | 43.7K | −59.3% | $3.2M | 0.9% |
PYXSPyxis Oncology, Inc. | 966.5K | +390.5% | $2.9M | 0.8% |
CMPXCompass Therapeutics, Inc. | 1M | +2,406.7% | $2.3M | 0.6% |
JBIOJade Biosciences, Inc. | 88.6K | New | $2M | 0.5% |
